Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q1HF
|
|||
Former ID |
DIB018793
|
|||
Drug Name |
NCGC00167772-01
|
|||
Synonyms |
10-DEBC
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C20H25ClN2O
|
|||
Canonical SMILES |
CCN(CC)CCCCN1C2=CC=CC=C2OC3=C1C=C(C=C3)Cl
|
|||
InChI |
1S/C20H25ClN2O/c1-3-22(4-2)13-7-8-14-23-17-9-5-6-10-19(17)24-20-12-11-16(21)15-18(20)23/h5-6,9-12,15H,3-4,7-8,13-14H2,1-2H3
|
|||
InChIKey |
GYBXAGDWMCJZJK-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:94104
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Serine/threonine-protein kinase pim-1 (PIM1) | Target Info | Inhibitor | [2] |
KEGG Pathway | Jak-STAT signaling pathway | |||
MicroRNAs in cancer | ||||
Acute myeloid leukemia | ||||
NetPath Pathway | IL9 Signaling Pathway | |||
IL5 Signaling Pathway | ||||
IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | ||||
TCR Signaling Pathway | ||||
Pathway Interaction Database | GMCSF-mediated signaling events | |||
Validated targets of C-MYC transcriptional activation | ||||
Role of Calcineurin-dependent NFAT signaling in lymphocytes | ||||
IL5-mediated signaling events | ||||
IL3-mediated signaling events | ||||
C-MYB transcription factor network | ||||
WikiPathways | Ectoderm Differentiation | |||
Hematopoietic Stem Cell Differentiation |
References | Top | |||
---|---|---|---|---|
REF 1 | Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling. J Biol Chem. 2005 Sep 9;280(36):31924-35. | |||
REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2158). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.